Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
for
Phenylketonuria (PKU)
Location: Boston MA, Pittsburgh PA, Atlanta GA, Indianapolis IN,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0+
Code: NCT06305234
Recruiting
Examining Interactions Between PALS and Caregivers
for
Amyotrophic Lateral Sclerosis (ALS)
Location: University Park PA
Sponsor: Penn State University
Sex: All
Age: 18 - 70+
Code: NCT06819124
Recruiting
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
for
Diabetic Foot Ulcer, Diabetic Foot,
Location: Monroeville PA
Sponsor: MiMedx Group, Inc.
Sex: All
Age: 18+
Code: NCT06600724
Recruiting
The Effect of Energy Drink Ingredients on Cardiovascular Function in Men and Women 18-39 Years Old
for
Cardiac Arrhythmia, Blood Pressure
Location: Pittsburgh PA
Sponsor: Duquesne University
Sex: All
Age: 18 - 39
Code: NCT04149717
Recruiting
Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
Location: South Orange NJ, Dover NJ, Bala-Cynwyd PA,
Sponsor: Bausch & Lomb Incorporated
Sex: All
Age: 22+
Code: NCT06060041
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Hartford CT, The Bronx NY, Montreal, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)